Dialysis fluid may hold key to detecting dangerous scarring early
NCT ID NCT07208513
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at fluid from peritoneal dialysis to find biological markers that could signal peritoneal fibrosis, a common complication. Researchers will analyze genetic material and metabolites from 55 participants, including dialysis patients and healthy controls. The goal is to develop a way to detect fibrosis earlier, potentially improving patient care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple test to detect peritoneal fibrosis early in dialysis patients, helping doctors adjust treatment sooner.
- What could go wrong
- This is an early observational study with only 55 participants, so findings may not apply to all patients. It aims to find clues, not prove a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL DIALYSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Renji Hospital
Shanghai, Shanghai Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New dialysis solution may delay need for full treatment in kidney patients
- One bag, not 24 hours: a simpler way to check dialysis quality
- Dialysis patients get a workout boost in new study
- Nighttime dialysis matches daytime in cleaning blood, study finds
- Kidney dialysis patients: new study tests blood thinner safety
- Can a smart monitor improve blood sugar control for dialysis patients?